• How health care is changing: Kaiser Permanente CEO Friday, 23 Jan 2015 | 7:13 AM ET
    Bernard Tyson at the 2015 WEF in Davos, Switzerland.

    Health care utilization is not dropping, but shifting toward a great focus on outpatient care, Bernard Tyson told CNBC.

  • FREETOWN, Sierra Leone— With the Ebola outbreak weakening in West Africa, Sierra Leone eased restrictions on movement and commercial activity Friday even as the president warned that the fight against the deadly disease is not yet over. But the number of new infections is now falling in Sierra Leone, Guinea and Liberia, the three most affected countries.

  • COPENHAGEN, Jan 23- Novo Nordisk, the world's biggest insulin maker, said on late Thursday it has received a positive opinion from the European regulatory authorities for its obesity treatment Saxenda. "Subject to the Commission's approval Novo Nordisk expects to launch Saxenda in several European markets starting in 2015," the company wrote in statement.

  • Workers comp upheld for Maine man who died on treadmill Thursday, 22 Jan 2015 | 3:53 PM ET

    PORTLAND, Maine— Maine's highest court on Thursday upheld workers' compensation benefits for the widow of a Salvation Army portfolio manager who died from a heart attack on a treadmill while monitoring the financial markets on TV and internal email on his BlackBerry. The Supreme Judicial Court unanimously rejected the Salvation Army's appeal of benefits...

  • Jan 22- A panel of experts on Thursday voted to recommend that U.S. health regulators approve Astellas Pharma Inc's drug for the treatment of rare, often fatal invasive fungal infections that can target patients with blood cancers. The Astellas medicine, which would be sold under the proposed brand name Cresemba, was granted Orphan Drug status by the FDA, which is...

  • DAVOS, Switzerland, Jan 22- The GAVI global vaccines alliance is seeking to raise $7.5 billion at a funding conference in Berlin next week, as its battle to prevent infectious diseases in millions of children reaches an expected peak. The economic benefits of that will be some $80 billion and $100 billion, underscoring the cost-effectiveness of vaccines as a...

  • LOS ANGELES— A major measles outbreak traced to Disneyland has brought criticism down on the small but vocal movement among parents to opt out of vaccinations for their children. In a rash of cases that public health officials are rushing to contain, at least 70 people in six states and Mexico have fallen ill since mid-December, most of them from California.

  • Jan 21- The U.S. Food and Drug Administration approved Novartis AG's injectable drug, Cosentyx, to treat adults with a moderate to severe skin disease called plaque psoriasis. Eli Lilly and Co will begin marketing its IL-17 inhibitor ixekizumab in the first half of 2015, while Amgen Inc and AstraZeneca Plc's brodalumab reported positive results from a...

  • FDA approves Novartis's psoriasis drug Wednesday, 21 Jan 2015 | 12:49 PM ET

    Jan 21- The U.S. Food and Drug Administration said it approved Novartis AG's drug to treat adults with moderate to severe plaque psoriasis.

  • *Resources pour into worst hotspot Freetown. FREETOWN, Jan 21- Here at the front line of the Ebola epidemic, the tide seems to be turning against the disease. A military-style operation to fight the outbreak in Sierra Leone- the worst-affected country- has helped to dramatically reduce new cases, in what health officials say is a major step towards defeating Ebola.

  • Paying less than $16 per hour not fair: Aetna CEO Wednesday, 21 Jan 2015 | 9:41 AM ET
    Mark Bertolini, CEO of Aetna at 2015 WEF in Davos, Switzerland.

    Aetna raised employees' wages to a base of $16 per hour because doing otherwise would have put workers in poverty, CEO Mark Bertolini tells CNBC.

  • LOS ANGELES— People who haven't been vaccinated against measles, including children too young to be immunized, should avoid Disneyland after new infections were linked to the theme park, California public health officials said Wednesday. The vast majority of infections— 62— occurred in California, and the tally is expected to rise. Disneyland Resorts...


  • Bristol-Meyers Squibb taps a doctor as new CEO Tuesday, 20 Jan 2015 | 5:29 PM ET
    Bristol-Myers Squibb R&D headquarters.

    Pharmaceutical giant Bristol-Myers Squibb named Dr. Giovanni Caforio as its new CEO on Tuesday.

  • Davos: Who needs a 'wake up call'?  Tuesday, 20 Jan 2015 | 11:25 AM ET

    Discussing the current state of Europe at Davos 2015, Karl-Ludwig Kley, chairman of Merck says the lack of coordination and cohesion in European businesses is the current problem.Meanwhile political leaders need a wake-up call.

  • WASHINGTON, Jan 20- The U.S. Supreme Court on Tuesday ruled for Teva Pharmaceutical Industries Ltd in its fight with generic drug manufacturers over patent protections for Copaxone, its top-selling multiple sclerosis drug, by sending the case back to a lower court for further review. On a 7-2 vote, the justices said that the U.S. Court of Appeals for the Federal...

  • WASHINGTON, Jan 20- The U.S. Supreme Court on Tuesday ruled for Teva Pharmaceutical Industries Ltd in its fight with generic drug manufacturers over patent protections for Copaxone, its top-selling multiple sclerosis drug, by sending the case back to a lower court for further review.


  • Shares of CytRx jumped Tuesday before markets opened after the drug developer said regulators have lifted a restriction placed on research into aldoxorubicin, a potential treatment for several forms of cancer. CytRx said it modified its research so it could avoid risks to patients and still study the drug's impact on several forms of cancer.

  • TRENTON, N.J.— Drugmaker AbbVie Inc. said Monday that its new, all-pill hepatitis C combo treatment has been approved for patients in the 28 European Union member countries. The company said the European Commission granted marketing authorization for the combination of Viekirax and Exviera. It's already approved in EU nonmembers Switzerland, Norway, Iceland...